1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Global Cell & Gene Therapy Drug Delivery Devices Market
4. Voice of Customer
5. Executive Summary
6. Global Cell &
Gene Therapy Drug Delivery Devices Market Outlook
6.1.
Market Size & Forecast
6.1.1.
By Value
6.2.
Market Share & Forecast
6.2.1.
By Type (Subretinal Injection Cannula, Extension Tube,
Intravenous Catheter, Sterile Insulin Syringe, Prefilled Syringe, Infusion Bags)
6.2.2.
By Commercialized Drugs (Luxturna, Kymriah, Yescarta,
Zolgensma, Provenge, Strimvelis)
6.2.3.
By Route of Administration (Oral, Intravenous, Ocular,
Transdermal, Others)
6.2.4.
By Method (In Vitro v/s Ex Vivo)
6.2.5.
By Company (2021)
6.2.6. By
Region
6.3.
Product Market Map
7. Asia-Pacific Cell
& Gene Therapy Drug Delivery Devices Market Outlook
7.1.
Market Size & Forecast
7.1.1.
By Value
7.2.
Market Share & Forecast
7.2.1.
By Type
7.2.2.
By Commercialized Drugs
7.2.3.
By Route of Administration
7.2.4.
By Method
7.2.5.
By Country
7.3.
Asia-Pacific: Country Analysis
7.3.1.
China Cell & Gene Therapy Drug Delivery Devices
Market Outlook
7.3.1.1.
Market Size & Forecast
7.3.1.1.1.
By Value
7.3.1.2.
Market Share & Forecast
7.3.1.2.1.
By Type
7.3.1.2.2.
By Commercialized Drugs
7.3.1.2.3.
By Route of Administration
7.3.1.2.4.
By Method
7.3.2.
India Cell & Gene Therapy Drug Delivery Devices
Market Outlook
7.3.2.1.
Market Size & Forecast
7.3.2.1.1.
By Value
7.3.2.2.
Market Share & Forecast
7.3.2.2.1.
By Type
7.3.2.2.2.
By Commercialized Drugs
7.3.2.2.3.
By Route of Administration
7.3.2.2.4.
By Method
7.3.3.
South Korea Cell & Gene Therapy Drug Delivery Devices
Market Outlook
7.3.3.1.
Market Size & Forecast
7.3.3.1.1.
By Value
7.3.3.2.
Market Share & Forecast
7.3.3.2.1.
By Type
7.3.3.2.2.
By Commercialized Drugs
7.3.3.2.3.
By Route of Administration
7.3.3.2.4.
By Method
7.3.4.
Japan Cell & Gene Therapy Drug Delivery Devices
Market Outlook
7.3.4.1.
Market Size & Forecast
7.3.4.1.1.
By Value
7.3.4.2.
Market Share & Forecast
7.3.4.2.1.
By Type
7.3.4.2.2.
By Commercialized Drugs
7.3.4.2.3.
By Route of Administration
7.3.4.2.4.
By Method
7.3.5.
Australia Cell & Gene Therapy Drug Delivery Devices
Market Outlook
7.3.5.1.
Market Size & Forecast
7.3.5.1.1.
By Value
7.3.5.2.
Market Share & Forecast
7.3.5.2.1.
By Type
7.3.5.2.2.
By Commercialized Drugs
7.3.5.2.3.
By Route of Administration
7.3.5.2.4.
By Method
8. Europe Cell &
Gene Therapy Drug Delivery Devices Market Outlook
8.1.
Market Size & Forecast
8.1.1.
By Value
8.2.
Market Share & Forecast
8.2.1.
By Type
8.2.2.
By Commercialized Drugs
8.2.3.
By Route of Administration
8.2.4.
By Method
8.2.5.
By Country
8.3.
Europe: Country Analysis
8.3.1.
France Cell & Gene Therapy Drug Delivery Devices
Market Outlook
8.3.1.1.
Market Size & Forecast
8.3.1.1.1.
By Value
8.3.1.2.
Market Share & Forecast
8.3.1.2.1.
By Type
8.3.1.2.2.
By Commercialized Drugs
8.3.1.2.3.
By Route of Administration
8.3.1.2.4.
By Method
8.3.2.
Germany Cell & Gene Therapy Drug Delivery Devices
Market Outlook
8.3.2.1.
Market Size & Forecast
8.3.2.1.1.
By Value
8.3.2.2.
Market Share & Forecast
8.3.2.2.1.
By Type
8.3.2.2.2.
By Commercialized Drugs
8.3.2.2.3.
By Route of Administration
8.3.2.2.4.
By Method
8.3.3.
United Kingdom Cell & Gene Therapy Drug Delivery
Devices Market Outlook
8.3.3.1.
Market Size & Forecast
8.3.3.1.1.
By Value
8.3.3.2.
Market Share & Forecast
8.3.3.2.1.
By Type
8.3.3.2.2.
By Commercialized Drugs
8.3.3.2.3.
By Route of Administration
8.3.3.2.4.
By Method
8.3.4.
Italy Cell & Gene Therapy Drug Delivery Devices
Market Outlook
8.3.4.1.
Market Size & Forecast
8.3.4.1.1.
By Value
8.3.4.2.
Market Share & Forecast
8.3.4.2.1.
By Type
8.3.4.2.2.
By Commercialized Drugs
8.3.4.2.3.
By Route of Administration
8.3.4.2.4.
By Method
8.3.5.
Spain Cell & Gene Therapy Drug Delivery Devices
Market Outlook
8.3.5.1.
Market Size & Forecast
8.3.5.1.1.
By Value
8.3.5.2.
Market Share & Forecast
8.3.5.2.1.
By Type
8.3.5.2.2.
By Commercialized Drugs
8.3.5.2.3.
By Route of Administration
8.3.5.2.4.
By Method
9. North America Cell
& Gene Therapy Drug Delivery Devices Market Outlook
9.1.
Market Size & Forecast
9.1.1.
By Value
9.2.
Market Share & Forecast
9.2.1.
By Type
9.2.2.
By Commercialized Drugs
9.2.3.
By Route of Administration
9.2.4.
By Method
9.2.5.
By Country
9.3.
North America: Country Analysis
9.3.1.
United States Cell & Gene Therapy Drug Delivery
Devices Market Outlook
9.3.1.1.
Market Size & Forecast
9.3.1.1.1.
By Value
9.3.1.2.
Market Share & Forecast
9.3.1.2.1.
By Type
9.3.1.2.2.
By Commercialized Drugs
9.3.1.2.3.
By Route of Administration
9.3.1.2.4.
By Method
9.3.2.
Mexico Cell & Gene Therapy Drug Delivery Devices
Market Outlook
9.3.2.1.
Market Size & Forecast
9.3.2.1.1.
By Value
9.3.2.2.
Market Share & Forecast
9.3.2.2.1.
By Type
9.3.2.2.2.
By Commercialized Drugs
9.3.2.2.3.
By Route of Administration
9.3.2.2.4.
By Method
9.3.3.
Canada Cell & Gene Therapy Drug Delivery Devices
Market Outlook
9.3.3.1.
Market Size & Forecast
9.3.3.1.1.
By Value
9.3.3.2.
Market Share & Forecast
9.3.3.2.1.
By Type
9.3.3.2.2.
By Commercialized Drugs
9.3.3.2.3.
By Route of Administration
9.3.3.2.4.
By Method
10. South America Cell
& Gene Therapy Drug Delivery Devices Market Outlook
10.1.
Market Size & Forecast
10.1.1.
By Value
10.2.
Market Share & Forecast
10.2.1.
By Type
10.2.2.
By Commercialized Drugs
10.2.3.
By Route of Administration
10.2.4.
By Method
10.2.5.
By Country
10.3.
South America: Country Analysis
10.3.1.
Brazil Cell & Gene Therapy Drug Delivery Devices
Market Outlook
10.3.1.1.
Market Size & Forecast
10.3.1.1.1.
By Value
10.3.1.2.
Market Share & Forecast
10.3.1.2.1.
By Type
10.3.1.2.2.
By Commercialized Drugs
10.3.1.2.3.
By Route of Administration
10.3.1.2.4.
By Method
10.3.2.
Argentina Cell & Gene Therapy Drug Delivery Devices
Market Outlook
10.3.2.1.
Market Size & Forecast
10.3.2.1.1.
By Value
10.3.2.2.
Market Share & Forecast
10.3.2.2.1.
By Type
10.3.2.2.2.
By Commercialized Drugs
10.3.2.2.3.
By Route of Administration
10.3.2.2.4.
By Method
10.3.3.
Colombia Cell & Gene Therapy Drug Delivery Devices
Market Outlook
10.3.3.1.
Market Size & Forecast
10.3.3.1.1.
By Value
10.3.3.2.
Market Share & Forecast
10.3.3.2.1.
By Type
10.3.3.2.2.
By Commercialized Drugs
10.3.3.2.3.
By Route of Administration
10.3.3.2.4.
By Method
11. Middle East and
Africa Cell & Gene Therapy Drug Delivery Devices Market Outlook
11.1.
Market Size & Forecast
11.1.1.
By Value
11.2.
Market Share & Forecast
11.2.1.
By Type
11.2.2.
By Commercialized Drugs
11.2.3.
By Route of Administration
11.2.4.
By Method
11.2.5.
By Country
11.3.
MEA: Country Analysis
11.3.1.
South Africa Cell & Gene Therapy Drug Delivery
Devices Market Outlook
11.3.1.1.
Market Size & Forecast
11.3.1.1.1.
By Value
11.3.1.2.
Market Share & Forecast
11.3.1.2.1.
By Type
11.3.1.2.2.
By Commercialized Drugs
11.3.1.2.3.
By Route of Administration
11.3.1.2.4.
By Method
11.3.2.
Saudi Arabia Cell & Gene Therapy Drug Delivery
Devices Market Outlook
11.3.2.1.
Market Size & Forecast
11.3.2.1.1.
By Value
11.3.2.2.
Market Share & Forecast
11.3.2.2.1.
By Type
11.3.2.2.2.
By Commercialized Drugs
11.3.2.2.3.
By Route of Administration
11.3.2.2.4.
By Method
11.3.3.
UAE Cell & Gene Therapy Drug Delivery Devices
Market Outlook
11.3.3.1.
Market Size & Forecast
11.3.3.1.1.
By Value
11.3.3.2.
Market Share & Forecast
11.3.3.2.1.
By Type
11.3.3.2.2.
By Commercialized Drugs
11.3.3.2.3.
By Route of Administration
11.3.3.2.4.
By Method
11.3.4.
Kuwait Cell & Gene Therapy Drug Delivery Devices
Market Outlook
11.3.4.1.
Market Size & Forecast
11.3.4.1.1.
By Value
11.3.4.2.
Market Share & Forecast
11.3.4.2.1.
By Type
11.3.4.2.2.
By Commercialized Drugs
11.3.4.2.3.
By Route of Administration
11.3.4.2.4.
By Method
12. Market Dynamics
12.1.
Drivers
12.2.
Challenges
13. Market Trends &
Developments
14. Competitive
Landscape
14.1.
Becton, Dickinson, and
Company
14.2.
Novartis AG
14.3.
Amgen Inc.
14.4.
Kite Pharma, Inc.
14.5.
Pfizer, Inc.
14.6.
Bausch & Lomb
Incorporated
14.7.
Bluebird bio, Inc.
14.8.
Castle Creek
Biosciences, Inc (Fibrocell Technologies, Inc.)
14.9.
Dendreon
Pharmaceuticals LLC.
14.10.
Helixmith Co., Ltd
(ViroMed Co., Ltd)
14.11.
Orchard Therapeutics
plc
14.12.
Renova Therapeutics
14.13.
Spark Therapeutics,
Inc.
14.14.
uniQure N.V.
14.15.
Vericel Corporation
15.
Strategic
Recommendations
In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com